Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. BioArctic AB (publ)
  6. Company
    BIOA B   SE0010323311

BIOARCTIC AB (PUBL)

(BIOA B)
  Report
Delayed Quote. Delayed Nasdaq Stockholm - 12/07 11:29:32 am
113.6 SEK   +3.09%
11/15BioArctic Develops New Antibody Treatment for ALS
CI
11/15BioArctic develops new antibody treatment for ALS
AQ
11/15New data on lecanemab presented at the CTAD Alzheimer conference
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
BioArctic AB is a Sweden-based company engaged in the biotechnology sector. The Company focuses on the research and development of treatments, which aim at diseases that affect the central nervous system (CNS). Its therapeutic areas encompass neurodegenerative disorders, Alzheimer's disease, Parkinson's disease, complete spinal cord injury, as well as other CNS disorders. The Company owns a technology platform, which develops a range of therapeutic monoclonal antibodies. The Company's pipeline includes product candidates in various clinical phases, such as BAN2401, AE1501, BAN0805, imaging and biochemical biomarkers, BBB-technology and SC0806. The Company also operates through SpineMedical AB.

Number of employees : 45 people.
Sales per Business
20192020Delta
Innovative Biological Drugs281.77100%62.35100% -77.87%
SEK in Million
Sales per region
20192020Delta
Europe119.8042.5%33.8154.2% -71.78%
Asia161.9857.5%28.5445.8% -82.38%
SEK in Million
Managers
Name Title Age Since
Gunilla Christina Osswald, Dr. President & Chief Executive Officer 59 2014
Jan P. Mattsson Chief Financial Officer & Vice President-Finance 60 2017
Christer M÷ller, Dr. Chief Scientific Officer 61 -
Tomas Odergren, Dr. Chief Medical Officer 61 2020
Lennart Rolf Ivar Verner Deputy Chairman 73 2017
Wenche Nelly A. Rolfsen Sandsborg, Dr. Chairman 68 2016
Eugen Steiner, Dr. Independent Director 66 2017
┼ke Mikael Smedeby Independent Director 52 -
Oskar Bosson VP-Communications & Investor Relations 44 2020
Pńr Lars Gellerfors, Dr. Director & Senior Vice President-Business Strategy 73 2014
Members of the board
Name Title Age Since
Wenche Nelly A. Rolfsen Sandsborg, Dr. Chairman 68 2016
Pńr Lars Gellerfors, Dr. Director & Senior Vice President-Business Strategy 73 2014
Lars Gunnar Lannfelt, Dr. Director 71 2016
Lennart Rolf Ivar Verner Deputy Chairman 73 2017
Eugen Steiner, Dr. Independent Director 66 2017
┼ke Mikael Smedeby Independent Director 52 -
Bengt Hňkan Englund Director 68 2020
Charlotta Ljungqvist, Dr. Director 59 2021
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 73,659,989 35,411,865 48.1% 0 0.0% 40.2%
Stock B 10 14,399,996 0 0.0% 0 0.0%
Shareholders
NameEquities%
Lars Gunnar Lannfelt 22,628,052 30.7%
Pńr Lars Gellerfors 15,086,301 20.5%
Fjńrde AP-fonden 4,000,000 5.43%
Tredje AP-fonden 3,810,032 5.17%
Unionen 2,391,835 3.25%
Swedbank Robur Fonder AB 2,085,306 2.83%
Investment AB Íresund (Investment Company) 1,530,000 2.08%
Andra AP-fonden 1,441,666 1.96%
Handelsbanken Fonder AB 1,440,103 1.96%
Wellington Management Co. LLP 1,314,848 1.79%
Company contact information
BioArctic AB
Warfvinges vńg 35
Stockholm 112 51

Phone : +46.8.6956930
Web : http://www.bioarctic.se
Brand Portfolio
In partnership withAllbrands.markets
More brands of BioArctic AB (publ)
Sector Other Biotechnology & Medical Research